Bilateral inguinal hernia repair Surgery Bilateral inguinal hernia repair
Conditions
Interventions
This study was carried out in a private hospital in Madrid (Spain) at the General Surgery Department of Sanchinarro University Hospital recruiting patients from March 2013. Patients (aged over 18 year
Sponsors
Sanchinarro University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged over 18 years 2. Primary, bilateral inguinal hernias assessed by ultrasound
Exclusion criteria
Exclusion criteria: Recurrent hernia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Clinical outcomes are measured as: 1.1. Time of surgery has been defined since the induction of general anaesthesia and recorded up to the close of the skin 1.2. Length of post-operative stay as well as postoperative complications have been prospectively recorded 1.3. Seroma is defined when it is symptomatic (pain, discomfort, etc..) and that tends to persist for long periods from surgery (> 1 month) and which often requires an interventional therapeutic approach (needle aspiration) 1.4. Postoperative pain was determinated at first and 7th day after surgery and at 2, 6 and 12 months, using the standardized 0-10 visual analgesic scale (VAS). After the discharge, it is gathered in outpatient clinic 1.5. Chronic pain was recorded and defined if it is lasting no less then 3 months after the hernia repair and which requires some analgesic drug 1.6. Number of outpatient surgical visits were also recorded as well as re admission or emergency visit without admission 2. Quality of life was assessed with the medical outcomes study SF-36 questionnaire (Spanish form) preoperatively and at 2, 6 and 12 months after surgery 3. Cost effectiveness is measured using incremental cost-effectiveness ratios (ICERs) at 1 years from surgery. The Institute of Validation of Efficacy Clinic (IVEC) of the HM Hospitals group is responsible for capturing costs ascribed to each patient’s treatment. The total direct hospital costs of care were recorded under the patient’s unique medical record number. | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrences are measured using outpatient visits after six months | — |
Countries
Spain
Outcome results
None listed